Alglucerase: the debate continues.
Push
S
S
D003362:Cost-Benefit Analysis; D005776:Gaucher Disease / Q000188:drug therapy* / Q000191:economics*; D005962:Glucosylceramidase / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D016896:Treatment Outcome